🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Screen2Prevent (S2P)

RecruitingNAAges 14 Years - 24 YearsAllWestat
NCT07728123 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrEP)/Antiretroviral treatment (ART).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 14-24 years, inclusive * Present to the participating ED, regardless of chief complaint during the study period Exclusion Criteria: * None
💊

What it tests

  • HIV screening strategies
📍

Where

5 sites
University of South Florida
Tampa, United States
Emory Atlanta Adolescent Consortium
Atlanta, United States
Johns Hopkins University
Baltimore, United States
St. Jude Children's Research Hospital
Memphis, United States
Baylor College of Medicine
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy